Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Nederlands onderzoek naar 'dirty money' wint Ig Nobelprijs
sep 2019 | Bacteriële infecties